A fully active nonglycosylated V2 vasopressin receptor

Molecular Pharmacology

Volumn 50, Issue 3, 1996, Pages 467-473

  Innamorati, Giulio ^a   Sadeghi, Hamid ^a   Birnbaumer, Mariel ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ASPARAGINE; GLUTAMINE; GLYCOSIDASE; RECEPTOR PROTEIN; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN GLYCOSYLATION; RECEPTOR DOWN REGULATION;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; ARGININE VASOPRESSIN; CELL LINE; CERCOPITHECUS AETHIOPS; EPITOPES; GENE EXPRESSION; GLYCOSIDE HYDROLASES; GLYCOSYLATION; GTP-BINDING PROTEINS; HUMANS; KIDNEY; KINETICS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; RECEPTORS, VASOPRESSIN; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0029786715     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Orloff, J., and J. S. Handler. The role of adenosine 3′,5′-phosphate in the action of antidiuretic hormone. Am. J. Med. 42:757-768 (1967).
2. Birnbaumer, M., and L. Birnbaumer. Signal transduction by G protein coupled receptors, in Membrane Functions in Health and Disease (S. M. Schultz, T. E. Andreoli, A. M. Brown, D. M. Fambrough, J. F. Hoffman, and M. J. Welsh, eds.). Plenum Press, New York, 321-366 (1996).
3. Nielsen, S., S. R. DiGiovanni, E. I. Christensen, M. A. Knepper, and H. W. Harris. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc. Natl. Acad. Sci. USA 90: 11663-11667 (1993).
4. Rosenthal, W., A. Seibold, A. Antaramian, M. Lonergan, M.-F. Arthus, G. N. M.-F., Hendy, M. Birnbaumer, and D. G. Bichet. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature (Lond.) 359:233-235 (1992).
5. Pan, Y., A. Metzenberg, S. Das, S., and J. Gitschier. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat. Genet. 2:103-106 (1992).
6. Deen, P. M., M. A. Verdijk, N. V. Knoers, B. Wieringa, L. A. Monnens, C. H. van Os, and B. A. van Oost. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science (Washington D. C.) 264:92-5 (1994).
7. Birnbaumer, M., A. Seibold, S. Gilbert, M. Ishido, C. Barberis, A. Antaramian, P. Brabet, and W. Rosenthal. Molecular cloning of the receptor for human antidiuretic hormone. Nature (Lond.) 357:333-335 (1992).
8. Lolait, S. J., A.-M. O'Carroll, O. W. McBride, M. Konig, A. Morel, and M. J. Brownstein. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature (Lond.) 357: 336-339 (1992).
9. 2 [8-lysine]vasopressin and oxytocin receptors from a pig kidney cell line. Eur. J. Biochem. 215:1-7 (1993).
10. Birnbaumer, M. ADH receptors: molecular biology and signal transduction, in Molecular Nephrology (J. V. Bonventre and D. Schlondorff, eds.). Marcel Dekker, New York, 517-524 (1995).
11. Jans, D. A., P. Jans, H. Luzius, and F. Fahrenholz. N-Glycosylation plays a role in biosynthesis and internalization of the adenylate cyclase stimulating vasopresain V2-receptor of LLC-PK1 renal epithelial cells: an effect of concanavalin A on binding and expression. Arch. Biochem. Biophys. 294:64-69 (1992).
12. Kaushal, S., K. D. Ridge, and H. G. Khorana. Structure and function in rhodopsin: the role of asparagine-linked glycosylation. Proc. Natl. Acad. Sci. USA 91:4024-4028 (1994).
13. Green, N., H. Alexander, A. Olson, S. Alexander, T. M. Shinnick, J. G. Sutcliffe, and R. A. Lerner. Immunogenic structure of the influenza virus hemagglutinin. Cell 28:477-487 (1982).
14. s/adenylyl cyclase system. Mol. Endocrinol. 8:886-894 (1994).
15. Sanger, F., S. Nicklen, and A. B. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977).
16. Luthman, H., and G. Magnusson. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11:1295-1308 (1983).
17. Graham, F. L., and A. J. Van der Eb. A new technique for the assay of infectivity of human adenovirus S DNA. Virology 52:456-467 (1973).
18. Keefer, J. R., and L. E. Limbird. The alpha 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of Madin-Darby canine kidney cells independent of coupling to pertussis toxin-sensitive GTP-binding proteins. J. Biol. Chem. 268:11340-11347 (1993).
19. Bockaert, J., M. Hunzicker-Dunn, and L. Birnbaumer. Hormone-stimulated desensitization of hormone-dependent adenylyl cyclase: dual action of luteinizing hormone on pig graafian follicle membranes. J. Biol. Chem. 251:2653-2663 (1976).
20. Salomon, Y., C. Londos, and M. Rodbell. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548 (1974).
21. Lowry, O. H., N. J. Rosebrough, O. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
22. Birnbaumer, M., A. Antaramian, A. P. N. Themmen, and S. Gilbert. Desensitization of the human V2 vasopressin receptor: homologous effects in the absence of heterologous desensitization. J. Biol. Chem. 267:11783-11788 (1992).
23. Sadeghi, H. M., G. Innamorati, and M. Birnbaumer. Maturation of receptor proteins in eukaryotic expression systems. J. Recept. Signal Transduct. Res., in press (1996).
24. Pan, Y., P. Wilson P, and J. Gitschier. The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J. Biol. Chem. 269:31933-31937 (1994).
25. Kojro, E., P. Eich, G. Gimpl, and F. Fahrenholz. Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. Biochemistry 32:13537-13544 (1993).
26. Sung, C.-H., B. G. Schneider, N. Agarwal, D. S. Papermaster, and J. Nathans. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88:8840-8844 (1991).
27. Rands, E., M. R. Candelore, A. H. Cheung, W. S. Hill, C. D. Strader, and R. A. Dixon. Mutational analysis of beta-adrenergic receptor glycosylation. J. Biol. Chem. 265:10759-10764 (1990).
28. Weinshank, R. L., J. M. Zgombick, M. Macchi, N. Adham, H. Lichtblau, T. A. Branchek, and P. R. Hartig. Cloning, expression, and pharmacological characterization of a human α2B-adrenergic receptor. Mol. Pharmacol. 38:681-688 (1990).
29. Maenhaut, C., J. Van Sande, F. Libert, M. Abramowicz, M. Parmentier, J. J. Vanderhaegen, J. E. Dumont, G. Vassart, and S. Schiffmann. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173:1169-1178 (1990).